SCHEMBL458970

SCHEMBL458970

CNC(=O)c1ccc(-c2cnc3c(NCC4CCOCC4)cc(Oc4cc(F)ccc4C)nn23)cc1C

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL469987 0.93 TTK (0.69) TTK
SCHEMBL10279540 0.93 TTK (0.69) TTK
SCHEMBL17590105 0.92 TTK (0.69) TTK
SCHEMBL17590102 0.90 TTK (0.66) TTK
SCHEMBL458770 0.88 TTK (0.74) TTK
SCHEMBL17590101 0.88 TTK (0.67) TTK
SCHEMBL15554683 0.87 TTK (0.56) TTK
SCHEMBL17590103 0.86 TTK (0.69) TTK
SCHEMBL456224 0.86 TTK (0.78) TTK
SCHEMBL10279128 0.85 TTK (0.68) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP claimed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO claimed
US-9255100-B2 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-02-09 US disclosed